Published in PLoS One on November 11, 2011
PAK signaling in cancer. Cell Logist (2012) 1.27
Evading apoptosis in cancer. Trends Cell Biol (2013) 1.17
The response to PAK1 inhibitor IPA3 distinguishes between cancer cells with mutations in BRAF and Ras oncogenes. Oncotarget (2012) 0.98
Molecular pathways: targeting RAC-p21-activated serine-threonine kinase signaling in RAS-driven cancers. Clin Cancer Res (2014) 0.89
PAK1 limits the expression of the pro-apoptotic protein Bad in pancreatic islet β-cells. FEBS Open Bio (2012) 0.81
TIMP-1 Inhibits Apoptosis in Lung Adenocarcinoma Cells via Interaction with Bcl-2. PLoS One (2015) 0.81
Sigma-1 receptor directly interacts with Rac1-GTPase in the brain mitochondria. BMC Biochem (2015) 0.78
p21-Activated kinase1 (Pak1) is a negative regulator of NADPH-oxidase 2 in ventricular myocytes. J Mol Cell Cardiol (2013) 0.77
Deciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer? Oncotarget (2016) 0.77
Protein microarray for complex apoptosis monitoring of dysplastic oral keratinocytes in experimental photodynamic therapy. Biol Res (2014) 0.76
Anti-cancer effect of novel PAK1 inhibitor via induction of PUMA-mediated cell death and p21-mediated cell cycle arrest. Oncotarget (2017) 0.75
Subverting Host Cell P21-Activated Kinase: A Case of Convergent Evolution across Pathogens. Pathogens (2017) 0.75
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell (1997) 21.42
Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF. Cell (2010) 17.48
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF. Nature (2010) 17.31
Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res (2003) 15.74
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth. Nature (2010) 15.63
Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L) Cell (1996) 10.83
A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature (1994) 9.18
Biology of the p21-activated kinases. Annu Rev Biochem (2003) 7.63
Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science (1999) 7.37
The BCL-2 family reunion. Mol Cell (2010) 7.32
PhosphoSite: A bioinformatics resource dedicated to physiological protein phosphorylation. Proteomics (2004) 5.55
p21-activated kinases in cancer. Nat Rev Cancer (2006) 4.24
14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell (2000) 4.05
Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell (1996) 4.04
An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase. Chem Biol (2008) 3.94
Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol Cell (1999) 3.46
Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat Cell Biol (1999) 3.17
Endothelial apoptosis in Braf-deficient mice. Nat Genet (1997) 2.77
Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta. Curr Biol (1999) 2.65
Pak protein kinases and their role in cancer. Cancer Metastasis Rev (2009) 2.44
p21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis. Mol Cell Biol (2000) 2.42
MEK kinase activity is not necessary for Raf-1 function. EMBO J (2001) 2.36
Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. EMBO J (2001) 2.32
Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155. Biochem J (2000) 2.06
Role of Raf in vascular protection from distinct apoptotic stimuli. Science (2003) 2.02
The genetics of Pak. J Cell Sci (2004) 2.00
Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth. Proc Natl Acad Sci U S A (2010) 1.94
BAD Ser-155 phosphorylation regulates BAD/Bcl-XL interaction and cell survival. J Biol Chem (2000) 1.94
Specificity profiling of Pak kinases allows identification of novel phosphorylation sites. J Biol Chem (2007) 1.92
Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery. Mol Cell (2002) 1.90
JNK phosphorylation and activation of BAD couples the stress-activated signaling pathway to the cell death machinery. J Biol Chem (2002) 1.80
The serine/threonine kinase PAK4 prevents caspase activation and protects cells from apoptosis. J Biol Chem (2001) 1.78
JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD. Mol Cell (2004) 1.73
p21-Activated kinase 5 (Pak5) localizes to mitochondria and inhibits apoptosis by phosphorylating BAD. Mol Cell Biol (2003) 1.57
Extracellular signal regulated kinase (ERK)/mitogen activated protein kinase (MAPK)-independent functions of Raf kinases. J Cell Sci (2002) 1.53
The Akt proto-oncogene links Ras to Pak and cell survival signals. J Biol Chem (2000) 1.53
p21-activated Kinase 1 (Pak1)-dependent phosphorylation of Raf-1 regulates its mitochondrial localization, phosphorylation of BAD, and Bcl-2 association. J Biol Chem (2005) 1.34
p21-activated protein kinase gamma-PAK suppresses programmed cell death of BALB3T3 fibroblasts. J Biol Chem (2001) 1.29
14-3-3 inhibits Bad-induced cell death through interaction with serine-136. Mol Pharmacol (2001) 1.27
Drug discovery: inhibitors that activate. Nature (2010) 1.22
Apoptosis suppression by Raf-1 and MEK1 requires MEK- and phosphatidylinositol 3-kinase-dependent signals. Mol Cell Biol (2001) 1.16
A role for Pak protein kinases in Schwann cell transformation. Proc Natl Acad Sci U S A (1998) 1.14
Signals from the Ras, Rac, and Rho GTPases converge on the Pak protein kinase in Rat-1 fibroblasts. Mol Cell Biol (1999) 1.07
An old kinase on a new path: Raf and apoptosis. Cell Death Differ (2002) 1.06
p21 activated kinase 5 activates Raf-1 and targets it to mitochondria. J Cell Biochem (2008) 0.96
Active p21-activated kinase 1 rescues MCF10A breast epithelial cells from undergoing anoikis. Neoplasia (2005) 0.96
Raf and the road to cell survival: a tale of bad spells, ring bearers and detours. Biochem Pharmacol (2003) 0.95
Rac1 inhibits apoptosis in human lymphoma cells by stimulating Bad phosphorylation on Ser-75. Mol Cell Biol (2004) 0.93
Identification of novel in vivo phosphorylation sites of the human proapoptotic protein BAD: pore-forming activity of BAD is regulated by phosphorylation. J Biol Chem (2009) 0.86
Pak protein kinases and their role in cancer. Cancer Metastasis Rev (2009) 2.44
The c-myb proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells. Blood (2008) 2.34
Opposing roles for Akt1 and Akt2 in Rac/Pak signaling and cell migration. J Biol Chem (2006) 1.94
c-Myb, Menin, GATA-3, and MLL form a dynamic transcription complex that plays a pivotal role in human T helper type 2 cell development. Blood (2010) 1.55
Akt phosphorylation of serine 21 on Pak1 modulates Nck binding and cell migration. Mol Cell Biol (2003) 1.44
p21-activated Kinase 1 (Pak1)-dependent phosphorylation of Raf-1 regulates its mitochondrial localization, phosphorylation of BAD, and Bcl-2 association. J Biol Chem (2005) 1.34
Reactive oxygen species generated by PAH o-quinones cause change-in-function mutations in p53. Chem Res Toxicol (2002) 1.28
PAK signaling in cancer. Cell Logist (2012) 1.27
c-Abl phosphorylates Dok1 to promote filopodia during cell spreading. J Cell Biol (2004) 1.26
Schwann cells: origins and role in axonal maintenance and regeneration. Int J Biochem Cell Biol (2006) 1.23
Rho, Rac, Pak and angiogenesis: old roles and newly identified responsibilities in endothelial cells. Cancer Lett (2005) 1.13
FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated Schwannomas. J Biol Chem (2013) 1.09
Proteolytic shedding of ST6Gal-I by BACE1 regulates the glycosylation and function of alpha4beta1 integrins. J Biol Chem (2008) 1.09
Mitochondrial shuttling of CAP1 promotes actin- and cofilin-dependent apoptosis. J Cell Sci (2008) 1.09
Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms. Exp Cell Res (2008) 1.09
Molecular changes in articular cartilage and subchondral bone in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. BMC Musculoskelet Disord (2011) 1.06
Activation of p21-activated kinase 1-nuclear factor kappaB signaling by Kaposi's sarcoma-associated herpes virus G protein-coupled receptor during cellular transformation. Cancer Res (2003) 0.99
Lysophosphatidic acid promotes survival and differentiation of rat Schwann cells. J Biol Chem (2003) 0.98
Comparison of p53 mutations induced by PAH o-quinones with those caused by anti-benzo[a]pyrene diol epoxide in vitro: role of reactive oxygen and biological selection. Chem Res Toxicol (2006) 0.97
Mammalian adenylyl cyclase-associated protein 1 (CAP1) regulates cofilin function, the actin cytoskeleton, and cell adhesion. J Biol Chem (2013) 0.96
Inverse relationship between matrix remodeling and lipid metabolism during osteoarthritis progression in the STR/Ort mouse. Arthritis Rheum (2007) 0.95
The pattern of p53 mutations caused by PAH o-quinones is driven by 8-oxo-dGuo formation while the spectrum of mutations is determined by biological selection for dominance. Chem Res Toxicol (2008) 0.95
Inhibition of cathepsin K reduces cartilage degeneration in the anterior cruciate ligament transection rabbit and murine models of osteoarthritis. Bone (2012) 0.91
cGMP-dependent protein kinase phosphorylates p21-activated kinase (Pak) 1, inhibiting Pak/Nck binding and stimulating Pak/vasodilator-stimulated phosphoprotein association. J Biol Chem (2006) 0.87
Oxidation of Akt2 kinase promotes cell migration and regulates G1-S transition in the cell cycle. Cell Cycle (2011) 0.83
Melamine and Cyanuric Acid do not interfere with Bradford and Ninhydrin assays for protein determination. Food Chem (2010) 0.82
Comparison of mesenchymal stem cell and osteosarcoma cell adhesion to hydroxyapatite. J Mater Sci Mater Med (2008) 0.81
p53 Mutagenesis by benzo[a]pyrene derived radical cations. Chem Res Toxicol (2012) 0.81
M-CSF induces the stable interaction of cFms with alphaVbeta3 integrin in osteoclasts. Int J Biochem Cell Biol (2006) 0.80
Aldo-keto reductases protect lung adenocarcinoma cells from the acute toxicity of B[a]P-7,8-trans-dihydrodiol. Chem Res Toxicol (2011) 0.80
The prevalence and determinants of drug-resistance-associated mutations in the HIV-1-infected MSM population of Henan Province in China. Arch Virol (2015) 0.78
The role of base excision repair genes OGG1, APN1 and APN2 in benzo[a]pyrene-7,8-dione induced p53 mutagenesis. Mutat Res (2012) 0.78
Self-association of arrestin family members. Handb Exp Pharmacol (2014) 0.78
Doxycycline up-regulates the expression of IL-6 and GM-CSF via MAPK/ERK and NF-κB pathways in mouse thymic epithelial cells. Int Immunopharmacol (2011) 0.77
The functional role of SUMO E3 ligase Mms21p in the maintenance of subtelomeric silencing in budding yeast. Biochem Biophys Res Commun (2013) 0.77
The histone acetyltransferase TIP60 interacts with c-Myb and inactivates its transcriptional activity in human leukemia. J Biol Chem (2011) 0.77
Role of the repressor Oaf3p in the recruitment of transcription factors and chromatin dynamics during the oleate response. Biochem J (2013) 0.76
Targeting PAK etk... Cancer Biol Ther (2004) 0.75
Amplifying Pak kinases. Cancer Biol Ther (2008) 0.75
Doxycycline Protects Thymic Epithelial Cells from Mitomycin C-Mediated Apoptosis In Vitro via Trx2-NF-x03BA;B-Bcl-2/Bax Axis. Cell Physiol Biochem (2016) 0.75
Erratum: CAP2 in cardiac conduction, sudden cardiac death and eye development. Sci Rep (2016) 0.75
Rapid and Quantitative Measurement of Single Quantum Dots in a Sheath Flow Cuvette. Anal Chem (2017) 0.75